Skip to main content
Log in

Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe

  • Published:
Infection Aims and scope Submit manuscript

Summary

There is an overwhelming consensus on the fact thatStreptococcus pneumoniae, Haemophilus influenzae andMoraxella catarrhalis represent the prevailing bacterial pathogens of community-acquired lower respiratory tract infections. Their specific incidence as causative agents of the more common syndromes is known to vary even profoundly depending on geographic location, and the same holds true for the rates of resistance to antimicrobial drugs. Europe does not escape the threat posed by the present pandemic spread of penicillin resistance inS. pneumoniae although, as expected, countries like Spain and France are greatly affected, while others including Germany, Italy, The Netherlands and the Scandinavian region are comparatively spared. In several sites multiple resistance has been described inS. pneumoniae and the most affected drugs include penicillin, the macrolides, co-trimoxazole and tetracycline. InH. influenzae synthesis of β-lactamases the main trait of resistance is expressed. Lack of susceptibility to β-lactams dictated by a different mechanism remains extremely rare. Considerable variations in the incidence of this characteristic are apparent when European countries are considered. France and Spain are again widely affected, while Germany, The Netherlands and Italy display rates of β-lactamase-positiveH. influenzae of about 10%.M. catarrhalis must be considered generally resistant to non-protected aminopenicillins since over 90% of these organisms produce β-lactamases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bisno, A. L., Gerber, M. A., Gwaltney, J. M. Jr., Kaplan, E. L., Schwartz, R. H.: Diagnosis and management of group A streptococcal pharyngitis: a practical guideline. Clin. Infect. Dis. 25 (1997) 574–583.

    PubMed  CAS  Google Scholar 

  2. Bartlett, J. G., Breiman, R. F., Mandell, L. A.: Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26 (1998) 811–838.

    PubMed  CAS  Google Scholar 

  3. Eskola, J., Hovi, T.: Respiratory viruses in acute otitis media. N. Engl. J. Med. 342 (1999) 312–313.

    Article  Google Scholar 

  4. Austrian, R.: The enduring pneumococcus: unfinished business and opportunities for the future. Microbiol. Drug Res. 3 (1997) 111–115.

    Article  CAS  Google Scholar 

  5. Tomasz, A.: Antibiotic resistance inStreptococcus pneumoniae. Clin. Infect. Dis. 24 (Suppl. 1) (1997) S85–88.

    Google Scholar 

  6. Kaplan, S. L., Manson, E. O. Jr.: Management of infections due to antibiotic-resistantStreptococcus pneumoniae. Clin. Microbiol. Rev. 11 (1998) 628–644.

    PubMed  CAS  Google Scholar 

  7. Craig, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26 (1998) 1–12.

    PubMed  CAS  Google Scholar 

  8. Felmingham, D., Gruneberg, R. N. andThe Alexander Project Group: A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992–1993: The Alexander Project. J. Antimicrob. Chemother. 30 (Suppl. A) (1996) 1–57.

    Google Scholar 

  9. Goldstein, F. W., Bryskier, A., Appelbaum, P. C., Bauernfeind, A., Jacobs, M., Schito, G. C., Wise, R.: The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory tract pathogens. Clin. Microbiol. Infect. 4 (Suppl. 2) (1998) S8–18.

    Google Scholar 

  10. Magliano, E. M., Osservatorio Epidemiologico Italiano: Introduzione, metodi e scopo della ricerca. GIMMOC 2 (1998) 7–14.

    Google Scholar 

  11. Schito, G. C., Mannelli, S., Debbia, E. A., Pesce, A., Marchese, A., Osservatorio Epidemiologico Italiano: Analisi del primo anno di monitoraggio delle resistenze agli antibiotici inStreptococcus pneumoniae: GIMMOC 2 (1998) 15–27.

    Google Scholar 

  12. Schito, G. C., Mannelli, S., Cibrario-Sent, M., Pesce, A., Marchese, A.: Evoluzione della eesistenze ai farmaci antibiomicrobici inStreptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano. GIMMOC 3 (1999) 43–57.

    Google Scholar 

  13. Dagan, R., Leibovitz, E., Greenberg, D., Yagupsky, P., Fliss, D., Leiberman, A.: Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Ped. Infect. Dis. J. 17 (1998) 776–782.

    Article  CAS  Google Scholar 

  14. Mazzaglia, G., Greco, S., Lando, C., Cucinotta, G., Caputi, A. P.: Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. J. Antimicrob. Chemother. 41 (1998) 256–266.

    Article  Google Scholar 

  15. Marchese, A., Ramirez, M., Schito, G. C., Tomasz, A.: Molecular epidemiology of penicillin-resistantStreptococcus pneumoniae isolated in Italy during 1993–1996. J. Clin. Microbiol. 36 (1998) 2944–2949.

    PubMed  CAS  Google Scholar 

  16. Marchese A., Tonoli, E., Debbia, E. A., Schito, G. C.: Macrolide resistance mechanisms and expression of phenotypes amongStreptococcus pneumoniae circulating in Italy. J. Antimicrob. Chemother. (in press 1999).

  17. Johnston, N. J., de Azavedo, J. C., Kellner, J. D., Low, D. E.: Prevalence and characterization of the mechanism of macrolide, lincosamide, and streptogramin resistance in isolates ofStreptococcus pneumoniae. Antimicrob. Agents Chemother. 42 (1998) 2425–2426.

    PubMed  CAS  Google Scholar 

  18. Sutcliffe, J., Tait-kamradt, A., Wondrack, L.:Streptococcus pneumoniae andStreptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40 (1996) 1817–1824.

    PubMed  CAS  Google Scholar 

  19. McDougal, L. K., Tenover, F. C.: Characterisation of macrolide resistance phenotypes inStreptococcus pneumoniae. In: Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstr. C-77b, p. 59. American Society for Microbiology, Washington DC., 1997.

    Google Scholar 

  20. Nicoletti, G., Aleo, G., Blandino, G., Russo, R., Speciale, A., Valenti, D., Caccamo, F.: Osservatorio epidemiologico italiano: analisis del 2° anno di monitoraggio delle resistenze agli antibiotici inH. influenzae eH. parainfluenzae. GIMMOC 3 (1999) 58–69.

    Google Scholar 

  21. Nicoletti, G., Speciale, A., Aleo, G., Blandino, G., Russo, R., Caccamo, F.: Osservatorio epidemiologico italiano: analisi del 2° anno di monitoraggio delle resistenze agli antibiotici inM. catarrhalis. GIMMOC 3 (1999) 70–80.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debbia, E.A., Shito, G.C., Pesce, A. et al. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. Infection 27 (Suppl 2), S9–S12 (1999). https://doi.org/10.1007/BF02561662

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02561662

Keywords

Navigation